QIMR BERGHOFER NOVEMBER LAB TOUR
Last week Cure Cancer Australia and their Principal Supporter, the Can Too Foundation, travelled to sunny Brisbane for a hugely insightful tour of the QIMR Berghofer Research Institute.
The November Lab Tour saw a group of Cure Cancer Australia and Can Too supporters, researchers and donors come together to learn more about the amazing cancer research being undertaken at the QIMR Berghofer Research Institute.
Established by the Australian government over 70 years ago, QIMR Berghofer is one of Australia’s most successful medical research institutes. The institute is focused on improving health by developing new diagnostics, better treatments and prevention strategies, specifically in the areas of cancer, infectious diseases, mental health and complex disorders.
Guests of the tour gathered for welcome presentations from Deputy Director Professor David Whiteman, Cure Cancer Australia Research Program Manager Kate Christian, and Can Too National Program Manager, Josan Abels. We then heard from three current Cure Cancer Australia grant recipients; Dr Rochelle D’Souza*, Dr Camille Guilleray* and A/Prof Steven Lane, who talked us through their current work, and how their Cure Cancer Australia grants have helped them to further their research.
The morning continued with a tour of the world-leading translational research institute, with groups led by QIMR-based researchers. Attendees were incredibly engaged, sharing personal stories about their own experiences with cancer, and posing interesting questions to the researchers which inspired a number of interesting discussions.
The tour concluded with breakfast refreshments, where guests were able to interact with one another and share their experiences and learnings.
A huge thank you to all those who took the time to participate. If you'd like to receive details about upcoming lab tours, contact firstname.lastname@example.org.
* Dr Camille Guilleray is co-funded by Cancer Australia through the Priority-driven Cancer Research Scheme. Dr Rochelle D’Souza and Dr Camille Guilleray are supported by the Can Too Foundation
# A/Prof Steven Lane is co-funded by Cancer Australia through the Priority-driven Cancer Research Scheme, supported by Kanga News and Kapstream Capital